Eric Mosbrooker
CIK 1715283 · Chief Commercial Officer · last filed 2026-02-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.12M
Companies
4
Total Filings
13
Lifetime Open-Market Net
-$6.37M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Avidity Biosciences, Inc. (RNAM) Delisted | Chief Commercial Officer | 0 | — | — | $0 | 1 | 2026-02-27 |
| RNA | Chief Commercial Officer | 90,436 | $12.37 | $1.12M | -$6.37M | 8 | 2025-12-19 |
| BOLD | SVP, Chief Commercial Officer | 0 | $1.41 | $0 | $0 | 3 | 2020-01-15 |
| Horizon Therapeutics Public Ltd Co (HZNP) Delisted | SVP, Orphan Business Unit | 5,900 | $116.30 | $686.2K | $0 | 1 | 2017-11-02 |
Recent Filings · Page 2 of 2
13 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-12-16 | BOLD | Tax (F) | −4,881 | -$289.8K | EDGAR |
| 2019-01-04 | BOLD | Grant (A) | +31,500 | $0 | EDGAR |
| 2017-11-02 | Horizon Therapeutics Public Ltd Co (HZNP) Delisted | Mixed | +2,120 | -$32.0K | EDGAR |
Showing 11–13 of 13
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.